NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fourth quarter revenues rose 11 percent, driven in part by double-digit growth in its molecular diagnostics business.

For the three months ended Sept. 30, the firm reported revenues of $802.9 million up from $726.8 million a year ago, beating the average consensus Wall Street estimate of $792.5 million. On a constant-currency basis, revenues rose 10 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.